Global Mice Model Market Overview
Mice Model Market Size was valued at USD 1.4 Billion in 2022. The Mice Model market industry is projected to grow from USD 1.5 Billion in 2023 to USD 2.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period (2024 - 2032). The rising incidence of diseases worldwide, including chronic conditions, infectious diseases, cancer, neurological disorders and autoimmune diseases, is one of the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Mice Model Market Trends
-
Rising incidence of diseases is driving the market growth
Market CAGR for the mice model is being driven by the rising incidence of diseases. As researchers seek to understand the underlying mechanisms of these diseases and develop effective treatments, mice models serve as indispensable tools in preclinical research. By mimicking human disease conditions, mice models enable researchers to study disease progression, test novel therapies, and evaluate treatment efficacy in a controlled environment. Additionally, the ability to create genetically modified mice with specific disease-relevant mutations allows researchers to gain valuable insights into disease mechanisms and potential therapeutic targets. As the demand for preclinical research models continues to grow in response to the rising burden of diseases, the use of mice models is expected to increase, further driving market growth.
The growing focus on precision medicine, which emphasizes personalized treatment approaches based on individual genetic and molecular characteristics, is a significant driver of the Mice Model Market. Mice models play a crucial role in precision medicine research by providing researchers with tools to study disease heterogeneity, treatment responses, and genetic susceptibility factors. By utilizing genetically diverse mice models, researchers can mimic the genetic variability observed in human populations, allowing for a more accurate representation of disease phenotypes and treatment outcomes. Additionally, mice models enable the development and testing of targeted therapies tailored to specific genetic mutations or molecular pathways associated with diseases. As precision medicine continues to gain prominence in healthcare, the demand for mice models for preclinical research aimed at developing personalized therapeutic strategies is expected to increase, driving market growth.
Drug development and safety assessment are key drivers of the Mice Model Market. Mice models play a crucial role in preclinical research for evaluating the safety and efficacy of new drug candidates before clinical trials. By utilizing mice models to study drug pharmacokinetics, pharmacodynamics, and toxicity profiles, researchers can identify potential adverse effects and optimize dosing regimens to enhance drug safety. Additionally, mice models allow for the investigation of drug interactions, metabolism, and distribution within the body, providing valuable insights into drug efficacy and potential side effects. With stringent regulatory requirements for drug approval, pharmaceutical companies rely on mice models to conduct comprehensive safety assessments and demonstrate the potential benefits of new therapies. As the demand for novel therapeutics continues to grow, the use of mice models in drug development and safety assessment is expected to drive market revenue growth.
Mice Model Market Segment Insights
Mice Model Model Type & Service Insights
The Mice Model Market segmentation, based on Model Type & Service includes Model Type (Inbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Outbred Mice), Service (Breeding, Cryopreservation, Rederivation, Quarantine and Other services). In 2023, the Model Type segment dominated the market, accounting for 15% of market revenue due to several reasons. First, the diverse range of model types available, including inbred, outbred, transgenic, and knockout mice, caters to the specific research requirements of various industries and academic institutions. Second, the availability of comprehensive services, such as breeding, genotyping, phenotyping, and disease modeling, offers researchers convenience and flexibility in obtaining customized mice models tailored to their experimental needs. This combination of diverse model types and comprehensive services drives the dominance of this segment in the market.
The Service Model Type & Service segment is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. First, increasing demand for customized mice models tailored to specific research needs drives the adoption of comprehensive services, including breeding, genotyping, and phenotyping. Second, outsourcing these services to specialized providers reduces operational costs and enhances research efficiency for pharmaceutical companies and academic institutions. Third, the growing trend towards outsourcing non-core activities further fuels the growth of this segment in the market.
Mice Model Technology Insights
The Mice Model Market segmentation, based on Technology, includes CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies. In 2023, the CRISPR/CAS9 category generated the most income due to its unparalleled precision, efficiency, and versatility in genetic engineering. This technology allows for the targeted modification of mouse genomes with unprecedented accuracy, enabling the creation of complex and precisely tailored mice models with specific genetic mutations relevant to human diseases. The widespread adoption of CRISPR/Cas9 technology by researchers and pharmaceutical companies underscores its dominance in driving innovation and advancements in mice model development.
Microinjection technology is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to its established reliability and versatility in generating genetically modified mice. This technique allows for the precise introduction of DNA constructs into mouse embryos, enabling the creation of transgenic and knockout mice models with targeted genetic modifications. As researchers continue to demand customized and complex mice models for various research applications, microinjection technology remains a preferred method for genetic manipulation, driving its growth in the market.
Mice Model Therapeutic Area Insights
The Mice Model Market segmentation, based on Therapeutic Area, includes Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases and Other Therapeutic Diseases. In 2023, the Oncology category generated the most income due to several factors. First, the increasing incidence of cancer worldwide drives demand for preclinical research models to study tumor biology, drug efficacy, and treatment response. Second, mice models enable researchers to mimic human cancer conditions, facilitating the development and testing of novel oncology therapies. Third, ongoing advancements in genetic engineering technologies allow for the creation of sophisticated mice models that accurately recapitulate human cancer pathology, further fueling demand in this therapeutic area.
The Metabolic Diseases Therapeutic Area is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. First, the rising prevalence of metabolic disorders such as diabetes, obesity, and metabolic syndrome drives the demand for preclinical models to study disease mechanisms and test potential therapies. Second, mice models allow researchers to investigate metabolic pathways, insulin resistance, and lipid metabolism, facilitating the development of novel treatments for metabolic diseases. This growing focus on metabolic disorders propels the demand for mice models in this therapeutic area, leading to the highest CAGR.
Mice Model Application Insights
The Mice Model Market segmentation, based on Application, includes Drug Discovery & Development, Research Application and Personalized Medicine. In 2023, the Drug Discovery & Development category generated the most income due to several key factors. First, mice models are indispensable tools in preclinical research for evaluating drug efficacy, safety, and pharmacokinetics. Second, their ability to accurately mimic human physiology and disease conditions enables researchers to screen potential drug candidates and assess their therapeutic potential before clinical trials. Third, ongoing advancements in genetic engineering technologies enhance the utility of mice models in drug discovery, solidifying their dominance in this application segment.
The Research Application segment is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. First, increasing investment in basic and translational research across academic and research institutions drives the demand for mice models for studying fundamental biological processes, disease mechanisms, and therapeutic interventions. Second, the versatility of mice models allows researchers to investigate a wide range of research areas, including immunology, neuroscience, genetics, and toxicology, contributing to the segment's rapid growth.
Mice Model End User Insights
The Mice Model Market segmentation, based on End User, includes Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and CROS & CDMOS. In 2023, the Pharmaceutical & Biotechnology Companies category generated the most income (due to several pivotal factors. These companies heavily rely on mice models for preclinical drug development, safety assessment, and efficacy testing, driving consistent demand. Secondly, the increasing focus on developing novel therapeutics and precision medicine approaches further propels the adoption of mice models by pharmaceutical and biotechnology companies. Lastly, ongoing advancements in genetic engineering technologies enhance the utility of mice models in drug discovery and development, solidifying their dominance in this end-user segment.
Academic & Research Institutes as an end user are experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several key factors. First, increasing investment in research and development activities across academic institutions and research centers drives the demand for mice models for basic and translational research. Second, collaborations between academia and industry foster innovation and drive the adoption of mice models in preclinical studies. Lastly, the growing focus on interdisciplinary research areas, including genetics, immunology, and neuroscience, further accelerates the demand for mice models among academic and research institutes, contributing to the segment's rapid growth.
Figure 1: Mice Model Market, by End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Mice Model Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. North America dominates the Mice Model Market for several reasons. Firstly, the region boasts a robust biomedical research ecosystem, with numerous academic institutions, pharmaceutical companies, and research organizations driving demand for mice models. Secondly, supportive government funding and regulatory frameworks encourage research and development activities in the region. Lastly, the presence of key market players and advanced infrastructure further strengthens North America's position as a leader in mice model research and development, contributing to its largest market share in the industry.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Mice Model Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Mice Model market accounts for the second-largest market share due to a well-established biomedical research infrastructure. Europe holds the second-largest market share in the Mice Model Market due to several factors. Firstly, the region features a well-established biomedical research infrastructure, with prominent academic institutions and research organizations driving demand for mice models. Secondly, supportive government initiatives and funding bolster research and development activities in Europe. Thirdly, the presence of leading pharmaceutical and biotechnology companies further contributes to the region's significant market share in mice model research and development. Further, the German Mice Model market held the largest market share, and the UK Mice Model market was the fastest growing market in the European region.
The Asia-Pacific Mice Model Market is expected to grow at the fastest CAGR from 2024 to 2032. The Asia Pacific region is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. Firstly, increasing investment in biomedical research and development across countries like China, Japan, and India drives demand for mice models. Secondly, rising pharmaceutical and biotechnology activities, coupled with a growing focus on personalized medicine, accelerate the adoption of mice models for preclinical research. Lastly, expanding collaborations between academia and industry further fuel market growth in the Asia Pacific region. Moreover, China’s Mice Model market held the largest market share, and the Indian Mice Model market was the fastest growing market in the Asia-Pacific region.
Mice Model Key Market Players & Competitive Insights
Leading players in the Mice Model Market are actively engaged in strategic initiatives to maintain their competitive edge. This includes expanding their product portfolios with innovative mice models, such as genetically engineered and humanized mice, to meet diverse market developments. Additionally, these players focus on enhancing their service offerings, including breeding, genotyping, and phenotyping services, to provide comprehensive solutions to researchers. Collaborations with academic institutions and pharmaceutical companies for research partnerships and licensing agreements also contribute to their competitive advantage.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Mice Model industry to benefit clients and increase the market sector. In recent years, the Mice Model industry has offered some of the most significant advantages to oncology. Major players in the Mice Model market, including Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others, are attempting to increase market demand by investing in research and development operations.
Charles River Laboratories International, Inc. is a leading provider of mice models and related services in the Mice Model Market. With a global presence spanning North America, Europe, Asia Pacific, and other regions, Charles River offers a comprehensive portfolio of genetically engineered, immunodeficient, and humanized mice models tailored for preclinical research across various therapeutic areas. The company's extensive expertise in breeding, genotyping, and phenotyping services ensures the delivery of high-quality, reliable research models to pharmaceutical, biotechnology, academic, and government institutions worldwide. Through strategic collaborations, acquisitions, and investments in technology and innovation, Charles River Laboratories continues to strengthen its position as a trusted partner in advancing biomedical research and drug discovery efforts aimed at addressing unmet medical needs.
Taconic Biosciences, Inc. is a prominent player in the Mice Model Market, offering a comprehensive range of genetically engineered mice models and related services. With a strong emphasis on innovation and quality, Taconic provides researchers worldwide with customized mice models tailored to specific research needs in various therapeutic areas. The company's extensive portfolio includes models for oncology, immunology, neurology, metabolic diseases, and more, facilitating preclinical research and drug discovery efforts. Taconic's commitment to customer satisfaction, along with its expertise in breeding, genotyping, and phenotyping services, ensures the delivery of reliable research models and support to pharmaceutical, biotechnology, and academic institutions globally. Through strategic partnerships and investments in research and development, Taconic Biosciences continues to drive advancements in the field of mice model research and preclinical studies.
Key Companies in the Mice Model market include
Mice Model Industry Developments
February 2024: The University of Texas Southwestern Medical Center unveiled a novel compound that markedly prolonged survival in a mouse model of amyotrophic lateral sclerosis (ALS) by inhibiting the function of a cluster of proteins known as MAP4Ks.
February 2023: Evotec SE has broadened its integrated multi-target drug discovery partnership with Related Sciences, a data-driven biotech creation company. The collaboration will persist in nurturing a joint portfolio of drug development candidates until 2030, utilizing Evotec's top-tier capabilities throughout the entire research and development process.
Mice Model Market Segmentation
Mice Model Model Type & Service Outlook
- Model Type
- Inbred Mice
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Outbred Mice
- Service
- Breeding
- Cryopreservation
- Rederivation
- Quarantine
- Other services
Mice Model Technology Outlook
- CRISPR/CAS9
- Microinjection
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Other Technologies
Mice Model Therapeutic Area Outlook
- Oncology
- Metabolic Diseases
- Immunology
- Neurology
- Cardiovascular Diseases
- Other Therapeutic Diseases
Mice Model Application Outlook
- Drug Discovery & Development
- Research Application
- Personalized Medicine
Mice Model End User Outlook
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROS & CDMOS
Mice Model Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
| Report Attribute/Metric |
Details |
| Market Size 2022 |
USD 1.4 Billion |
| Market Size 2023 |
USD 1.5 Billion |
| Market Size 2032 |
USD 2.4 Billion |
| Compound Annual Growth Rate (CAGR) |
6.20% (2024-2032) |
| Base Year |
2023 |
| Market Forecast Period |
2024-2032 |
| Historical Data |
2019-2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Model Type & Service, Technology, Therapeutic Area, Application, End User and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
 Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others |
| Key Market Opportunities |
·        Advanced Genetic Engineering Technologies and Collaborations and Partnerships |
| Key Market Dynamics |
·        Rising Incidence of Diseases and Growing Focus on Precision Medicine |
Frequently Asked Questions (FAQ) :
The Mice Model Market size was valued at USD 1.5 Billion in 2023.
The global market is projected to grow at a CAGR of 6.20% during the forecast period, 2024-2032.
North America had the largest share in the global market
The key players in the market are Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others Company.
The Oncology category dominated the market in 2023.
The Drug Discovery & Development category had the largest share in the global market.
